AFACTT ECI Satellite Symposium – Amsterdam – 2 September 2018, 10.00- 14.30 – RAI Amsterdam
No additional fee but registration required – Limited places – Closing date registration: 1 September 2018
CALL FOR ABSTRACTS
Advancements in Tolerance-inducing cellular therapies – an update by AFACTT
The AFACTT consortium, – EU COST Action to Focus and Accelerate Cell-based Tolerance-inducing Therapies – is proud to announce that it will organize its own AFACTT ECI satellite symposium in the framework of the European Congress of Immunology (ECI), which will take place in Amsterdam (2-5 September 2018).
The symposium is a great opportunity for attendants to gain knowledge on the progress in the field of Tolerance Inducing Cellular Therapies (e.g. tolerogenic dendritic cells and Tregs). Starting with inspiring talks of AFACTT consortium members the symposium seeks also to interactively exchange and discuss insights and views with attendants.
In this framework, AFACTT opens a CALL FOR ABSTRACTS. From the submitted abstracts two authors will be selected and are invited to give a short talk. To participate in the Call, please fill out the Title of the abstract in the registration form. You will then receive further details on the Call and how to proceed.
The AFACTT satellite meeting is open to everyone, without additional fees, but registration is required. Due to limited places, admission is based on first registration.
(Subject to updates)
2 SEPTEMBER – 10.00- 14.30
The ONE Study – clinical trials testing immune cell therapy in kidney transplant recipients.
Ed Geissler (Regensburg, Germany)
Tolerogenic mesenchymal stem cells in corneal transplantation- from bench to bedside.
Thomas Ritter (Galway, Ireland)
What is the Minimum Information in tolerogenic therapies. MITAP, MITREG and beyond.
Piotr Trzonkowski (Gdansk, Poland) and Catharien Hilkens (Newcastle, UK):
Stability of Treg
Irma Joosten (Nijmegen, the Netherlands)
Authors of 2 selected abstracts
Including lots of time to exchange ideas, views and insights with and among attendants.